300962.SHE Zhongjin Irradiation Incorporated Company
- Market cap
- CNY 3.45B
- P/E
- 19.5x
- P/B
- 2.99x
- ROE
- 17.2%
- Dividend yield
- 1.03%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300962.SHE undervalued?
Graham number300962.SHE trades 60.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zhongjin Irradiation Incorporated Company fundamental analysis
No fundamental analysis for Zhongjin Irradiation Incorporated Company yet.
Zhongjin Irradiation Incorporated Company stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zhongjin Irradiation Incorporated Company
Zhongjin Irradiation Incorporated Company provides irradiation technology services in China. It provides irradiation sterilization services for medical and health care products, food, pharmaceuticals, daily necessities, packaging materials, and other products; irradiation modification services for polymer materials; scientific and sterilization technology solutions; and disinfection and sterilization services for reusable diagnostic and treatment instruments, equipment, nurs…
Full company profileZhongjin Irradiation Incorporated Company financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Zhongjin Irradiation Incorporated Company annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 207M | 214M | 244M | 253M | 256M | 309M | 337M | 345M | 359M | 364M | 375M |
| Gross Profit | 118M | 120M | 134M | 143M | 144M | 188M | 214M | 218M | 224M | 218M | 214M |
| Operating Income | 49.4M | 45.6M | 59.8M | 68.7M | 72.8M | 110M | 128M | 128M | 130M | 146M | 114M |
| EBITDA | 55.4M | 60.6M | 73.1M | 139M | 141M | 176M | 192M | 195M | 200M | 244M | 272M |
| Net Income | 31.3M | 38.9M | 52.5M | 58.3M | 61.5M | 87.1M | 108M | 108M | 109M | 119M | 199M |
| EPS | 0.17 | 0.21 | 0.28 | 0.29 | 0.31 | 0.35 | 0.41 | 0.41 | 0.41 | 0.45 | 0.75 |
| Balance Sheet | |||||||||||
| Total Assets | 746M | 740M | 758M | 759M | 730M | 1.00B | 1.07B | 1.10B | 1.14B | 1.32B | 1.62B |
| Total Liabilities | 235M | 190M | 141M | 133M | 101M | 124M | 152M | 152M | 155M | 242M | 406M |
| Shareholders' Equity | 484M | 523M | 590M | 599M | 601M | 846M | 887M | 916M | 948M | 1.03B | 1.15B |
| Cash & Short-term Investments | 50.4M | 39.4M | 86.7M | 62.0M | 38.1M | 315M | 322M | 353M | 314M | 267M | 270M |
| Total Debt | 126M | 100M | 60.0M | 50.0M | 30.0M | 9.53M | 7.94M | 10.9M | 6.60M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | - | 126M | 147M | 126M | 141M | 176M | 185M | 188M | 194M | 217M | - |
| Capital Expenditure | 97.0M | 108M | 69.1M | 89.0M | 84.5M | 65.1M | 118M | 85.3M | 164M | 305M | 355M |
| Free Cash Flow | -97.0M | 18.5M | 78.1M | 36.9M | 56.0M | 110M | 67.4M | 103M | 30.3M | -87.7M | -249M |
| Ratios | |||||||||||
| ROE | 6.5% | 7.4% | 8.9% | 9.7% | 10.2% | 10.3% | 12.1% | 11.8% | 11.5% | 11.5% | 17.2% |
| ROA | 4.2% | 5.3% | 6.9% | 7.7% | 8.4% | 8.7% | 10.1% | 9.8% | 9.5% | 9.0% | 12.3% |
| Net Profit Margin | 15.1% | 18.2% | 21.5% | 23.0% | 24.0% | 28.2% | 32.0% | 31.3% | 30.4% | 32.6% | 53.0% |
| Debt to Equity | 0.26x | 0.19x | 0.10x | 0.08x | 0.05x | 0.01x | 0.01x | 0.01x | 0.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Zhongjin Irradiation Incorporated Company dividends
- Dividend yield
- 1.03%
- Forward dividend
- 0.09 CNY
- Payout ratio
- 29.8%
- Ex-dividend date
- Jul 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 35.4M | 0.13 | 29.8% |
| 2024 | CNY 69.2M | 0.26 | 63.6% |
| 2023 | CNY 73.9M | 0.28 | 68.4% |
| 2022 | CNY 66.0M | 0.25 | 61.3% |
| 2021 | CNY 39.2M | 0.16 | 45.0% |
| 2020 | CNY 60.7M | 0.31 | 98.7% |
| 2019 | CNY 51.3M | 0.26 | 88.0% |
| 2018 | 44.3M | 0.23 | 84.5% |
| 2017 | 5.55M | 0.03 | 14.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Zhongjin Irradiation Incorporated Company
- Insiders 62.71%
- Institutions 0.57%
- Public & others 36.72%
- Shares outstanding 264M
- Free float 112M
Zhongjin Irradiation Incorporated Company company profile
- Company name
- Zhongjin Irradiation Incorporated Company
- Ticker
- 300962.SHE
- ISIN
- CNE100004K78
- Exchange
- Shenzhen Stock Exchange
- Sector
- Industrials
- Industry
- Machinery
- Employees
- 672
- Fiscal year end
- December
- Address
- No. 1028, Building B, Buji Road, Shenzhen, China, 518019
- Phone
- 86 75 5251 77228
- Website
- zjfz.chinagoldgroup.com
About Zhongjin Irradiation Incorporated Company
Zhongjin Irradiation Incorporated Company provides irradiation technology services in China. It provides irradiation sterilization services for medical and health care products, food, pharmaceuticals, daily necessities, packaging materials, and other products; irradiation modification services for polymer materials; scientific and sterilization technology solutions; and disinfection and sterilization services for reusable diagnostic and treatment instruments, equipment, nursing kits, and surgical packs. The company also provides inspection and testing services, such as testing, verification and consulting services for irradiation technology services. Zhongjin Irradiation Incorporated Company was incorporated in 2003 and is headquartered in Shenzhen, China.
Zhongjin Irradiation Incorporated Company management
3- Mr. Dongbo ZhangGeneral Manager · born 1965
- Mr. Zhengjin LiuChief Accountant · born 1978
- Mr. Jun ChenDeputy GM, Secretary, General Counsel & Chief Compliance Officer · born 1977